Quality of Care for Veterans with Chronic Diseases: Performance on Quality Indicators, Medication Use and Adherence, and Health Care Utilization

Neugaard, Britta; Priest, Julie; Burch, Steven; Cantrell, C. Ron; Foulis, Philip

doi:10.1089/pop.2010.0020

Cited by 31 publications

(21 citation statements)

References 17 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although several medications are available to prevent and control COPD symptoms and exacerbations, a large proportion of COPD patients remain untreated 16. Furthermore, medication adherence levels for mCOPD medications have been found to be suboptimal and lower than the levels typically observed for treatments for other conditions 5–8. One of the reasons for suboptimal adherence to COPD medications may be due to the symptomatic nature of the disease leading to adjustment of medication use depending on how the patients feel on any particular day 9.…”

Section: Discussionmentioning

confidence: 99%

“…Medication adherence levels for COPD medications have been found to be well below the levels typically observed for treatments for other conditions 5–8. For example, in a 2011 study of US military veterans, proportion of patients adherent to COPD treatments, defined as proportion of days covered (PDC) ≥0.80, was reported to be approximately 30% versus 40%–63% for coronary artery diseases, diabetes, heart failure, and hyperlipidemia treatments 8…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients

Dhamane

Schwab

Hopson

et al. 2016

COPD

View full text Add to dashboard Cite

BackgroundPatients with COPD often have multiple comorbidities requiring use of multiple medications, and adherence rates for maintenance COPD (mCOPD) medications are already known to be suboptimal. Presence of comorbidities in COPD patients, and use of medications used to treat those comorbidities (non-COPD medications), may have an adverse impact on adherence to mCOPD medications.ObjectiveThe objective of the study was to evaluate the association between non-adherence to mCOPD medications and non-COPD medications in COPD patients.MethodsCOPD patients were identified using a large administrative claims database. Selected patients were 40–89 years old and continuously enrolled for 12 months prior to and 24 months after the first identified COPD diagnosis (index date) during January 1, 2009 to December 31, 2010. Patients were required to have ≥1 prescription for a mCOPD medication within 365 days of the index date and ≥1 prescription for one of 12 non-COPD medication classes within ±30 days of the first COPD prescription. Adherence (proportion of days covered [PDC]) was measured during 365 days following the first COPD prescription. The association between non-adherence (PDC <0.8) to mCOPD and non-adherence to non-COPD medications was determined using logistic regression, controlling for baseline patient characteristics.ResultsA total of 14,117 patients, with a mean age of 69.9 years, met study criteria. Of these, 40.9% were males and 79.2% were non-adherent to mCOPD medications with a mean PDC of 0.47. Non-adherence to mCOPD medications was associated with non-adherence to 10 of 12 non-COPD medication classes (odds ratio 1.38–1.78, all P<0.01).ConclusionAdherence to mCOPD medications is low. Non-adherence (or adherence) to mCOPD medications is positively related to non-adherence (or adherence) to non-COPD medications, implying that the need to take medications prescribed for comorbid conditions does not adversely impact adherence to mCOPD medications.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients

Dhamane

Schwab

Hopson

et al. 2016

COPD

View full text Add to dashboard Cite

show abstract

“…However, unlike other chronic diseases, medication adherence in COPD has found to be quite low [2][3][4]. For instance, in a previous study Neugaard et al [5] showed that among US military veterans, COPD medication adherence was 30%, whereas for coronary artery diseases, diabetes, heart failure, and hyperlipidemia treatments, the adherence was 40%-63%. Multiple factors, including patient beliefs, knowledge, and attitude, regarding to both illness and therapy have shown to be equally important in medication adherence as with social, demographic, and clinical factors in patients with COPD [6].…”

Section: Introductionmentioning

confidence: 99%

Cross-cultural Adaptation and Validation of Beliefs about Medicines Questionnaire on Asthma and Chronic Obstructive Pulmonary Disease Patients

Arıkan¹,

Duman²,

Kargın³

et al. 2018

Turk Thorac J

View full text Add to dashboard Cite

OBJECTIVES:Inadequate adaptation to long-term treatment of chronic illnesses is the most common reason for the inability to obtain the benefits medications can provide. Treatment compliance is influenced by several factors. Beliefs about Medicines Questionnaire (BMQ) developed by Horne et al. in 1999 to evaluate the cognitive representation of medicines have many validation studies, which resulted in good psychometric properties. The aim of the present study was to evaluate the reliability and validity of the BMQ Turkish translation in patients with asthma and chronic obstructive pulmonary disease (COPD). MATERIAL AND METHODS:Fifty asthma and 50 COPD patients participated in this methodological study. The scale was adapted to Turkish through translation, comparison with other language versions, back translation, and a pre-test. The structural validity was assessed using factor analysis. RESULTS:Similar to the original scale, factor analysis confirmed that BMQ had a four-factor structure that accounts for 58.23% of the total variance. The BMQ showed an acceptable internal consistency (Cronbach's alpha coefficient: specific-necessity, 0.832: specificconcerns, 0.722; general-harm, 0.792; and general-overuse, 0.682). The factor analysis revealed the same patterns for all questions between the Turkish and original scales. CONCLUSION:The psychometric properties of the BMQ were consistent with those reported in the original study. We found that the Turkish translation of BMQ is a valid and reliable tool for assessing medicine-related beliefs in patients with asthma and COPD.

show abstract

“…Currently, 8.76 million veterans 65 years or older are enrolled in the VHA health care system, with 75% of those having 1 or more chronic disease process. [11][12][13][14][15][16] Veterans 85 years or older increased by 190% between 2000 and 2010, whereas the general US population of the same age rose by only 44%. 17 Many of the symptoms associated with chronic disease processes leave individuals physically and cognitively debilitated, making routine care more difficult to obtain.…”

mentioning

confidence: 99%

Symptom Management of Chronic Illness in the Adult Outpatient Setting

Bushor

Rowser

2015

Journal of Hospice & Palliative Nursing

View full text Add to dashboard Cite

Quality of Care for Veterans with Chronic Diseases: Performance on Quality Indicators, Medication Use and Adherence, and Health Care Utilization

Abstract: This study was conducted to assess and benchmark the quality of care,

Cited by 31 publications

References 17 publications

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients

Cross-cultural Adaptation and Validation of Beliefs about Medicines Questionnaire on Asthma and Chronic Obstructive Pulmonary Disease Patients

Symptom Management of Chronic Illness in the Adult Outpatient Setting

Contact Info

Product

Resources

About